Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Assessing the Psychedelic "After-Glow" in Ayahuasca Users, Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities

  • Riba Serrano, Jordi
  • Sampedro, Frederic|||0000-0002-3933-1355
  • Vilà Canet, Gemma
  • de la Fuente Revenga, Mario
  • Valle, Marta|||0000-0002-3515-251X
  • Roberto Herrero, Natalia|||0000-0002-5391-2711
  • Dominguez-Clave, Elisabet|||0000-0001-6528-0064
  • Elices, M.|||0000-0002-7034-4242
  • Luna, Luís Eduardo
  • Crippa, José A. S.
  • Hallak, Jaime E. C.
  • de Araujo, Draulio B.
  • Friedlander, Pablo
  • Barker, Steven A..
  • Álvarez Martínez, Enric|||0000-0002-5180-5541
  • Soler, Joaquim|||0000-0001-8077-3641
  • Pascual, Juan Carlos|||0000-0001-8039-9346
  • Feilding, Amanda|||0000-0002-1329-1893
Ayahuasca is a plant tea containing the psychedelic 5-HT agonist N,N -dimethyltryptamine and harmala monoamine-oxidase inhibitors. Acute administration leads to neurophysiological modifications in brain regions of the default mode network, purportedly through a glutamatergic mechanism. Post-acutely, ayahuasca potentiates mindfulness capacities in volunteers and induces rapid and sustained antidepressant effects in treatment-resistant patients. However, the mechanisms underlying these fast and maintained effects are poorly understood. Here, we investigated in an open-label uncontrolled study in 16 healthy volunteers ayahuasca-induced post-acute neurometabolic and connectivity modifications and their association with mindfulness measures. Using 1 H-magnetic resonance spectroscopy and functional connectivity, we compared baseline and post-acute neurometabolites and seed-to-voxel connectivity in the posterior and anterior cingulate cortex after a single ayahuasca dose. Magnetic resonance spectroscopy showed post-acute reductions in glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex. Connectivity was increased between the posterior cingulate cortex and the anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe. Glutamate+glutamine reductions correlated with increases in the "nonjudging" subscale of the Five Facets Mindfulness Questionnaire. Increased anterior cingulate cortex-medial temporal lobe connectivity correlated with increased scores on the self-compassion questionnaire. Post-acute neural changes predicted sustained elevations in nonjudging 2 months later. These results support the involvement of glutamate neurotransmission in the effects of psychedelics in humans. They further suggest that neurometabolic changes in the posterior cingulate cortex, a key region within the default mode network, and increased connectivity between the anterior cingulate cortex and medial temporal lobe structures involved in emotion and memory potentially underlie the post-acute psychological effects of ayahuasca.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Intrinsically regulated learning is modulated by synaptic dopamine signaling

  • Ripollés, Pablo|||0000-0002-8463-3723
  • Ferreri, Laura
  • Mas-Herrero, Ernest|||0000-0002-3607-8489
  • Alicart, Helena
  • Gómez-Andrés, Alba
  • Marco-Pallarés, Josep|||0000-0001-9175-1480
  • Antonijoan Arbós, Rosa Ma|||0000-0002-7099-5125
  • Noesselt, Toemme|||0000-0002-9611-9713
  • Valle, Marta|||0000-0002-3515-251X
  • Riba, Jordi|||0000-0002-9375-8421
  • Rodriguez-Fornells, Antoni|||0000-0002-3249-6931
We recently provided evidence that an intrinsic reward-related signal-triggered by successful learning in absence of any external feedback -modulated the entrance of new information into long-term memory via the activation of the dopaminergic midbrain, hippocampus, and ventral striatum (the SN/VTA-Hippocampal loop; Ripollés et al., 2016). Here, we used a double-blind, within-subject randomized pharmacological intervention to test whether this learning process is indeed dopamine-dependent. A group of healthy individuals completed three behavioral sessions of a language-learning task after the intake of different pharmacological treatments: a dopaminergic precursor, a dopamine receptor antagonist or a placebo. Results show that the pharmacological intervention modulated behavioral measures of both learning and pleasantness, inducing memory benefits after 24 hr only for those participants with a high sensitivity to reward. These results provide causal evidence for a dopamine-dependent mechanism instrumental in intrinsically regulated learning and further suggest that subject-specific reward sensitivity drastically alters learning success.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans

  • Maqueda, Ana Elda
  • Valle, Marta|||0000-0002-3515-251X
  • Addy, Peter H.
  • Antonijoan Arbós, Rosa Ma|||0000-0002-7099-5125
  • Puntes, Montserrat
  • Coimbra, Jimena
  • Ballester, Maria Rosa|||0000-0002-0472-9558
  • Garrido, Maite
  • González, Mireia
  • Claramunt, Judit
  • Barker, Steven|||0000-0002-5755-3496
  • Lomnicka, Izabela
  • Waguespack, Marian
  • Johnson, Matthew W.
  • Griffiths, Roland R.
  • Riba, Jordi|||0000-0002-9375-8421
Salvinorin-A is a terpene found in the leaves of the plant Salvia divinorum. When administered to humans, salvinorin-A induces an intense but short-lasting modified state of awareness, sharing features with those induced by the classical serotonin-2A receptor agonist psychedelics. However, unlike substances such as psilocybin or mescaline, salvinorin-A shows agonist activity at the kappa-opioid receptor rather than at the serotonin-2A receptor. Here, we assessed the involvement of kappa-opioid receptor and serotonin-2A agonism in the subjective, cardiovascular, and neuroendocrine effects of salvinorin-A in humans. We conducted a placebo-controlled, randomized, double-blind study with 2 groups of 12 healthy volunteers with experience with psychedelic drugs. There were 4 experimental sessions. In group 1, participants received the following treatment combinations: placebo+placebo, placebo+salvinorin-A, naltrexone+placebo, and naltrexone+salvinorin-A. Naltrexone, a nonspecific opioid receptor antagonist, was administered at a dose of 50mg orally. In group 2, participants received the treatment combinations: placebo+placebo, placebo+salvinorin-A, ketanserin+placebo, and ketanserin+salvinorin-A. Ketanserin, a selective serotonin-2A antagonist, was administered at a dose of 40mg orally. Inhalation of 1mg of vaporized salvinorin-A led to maximum plasma concentrations at 1 and 2 minutes after dosing. When administered alone, salvinorin-A severely reduced external sensory perception and induced intense visual and auditory modifications, increased systolic blood pressure, and cortisol and prolactin release. These effects were effectively blocked by naltrexone, but not by ketanserin. Results support kappa opioid receptor agonism as the mechanism of action underlying the subjective and physiological effects of salvinorin-A in humans and rule out the involvement of a serotonin-2A-mediated mechanism.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans

  • Maqueda, Ana Elda
  • Valle, Marta|||0000-0002-3515-251X
  • Addy, Peter H.
  • Antonijoan Arbós, Rosa Ma|||0000-0002-7099-5125
  • Puntes, Montserrat
  • Coimbra, Jimena
  • Ballester, Maria Rosa|||0000-0002-0472-9558
  • Garrido, Maite
  • González, Mireia
  • Claramunt, Judit
  • Barker, Steven|||0000-0002-5755-3496
  • Johnson, Matthew W.
  • Griffiths, Roland R.
  • Riba, Jordi|||0000-0002-9375-8421
Salvinorin-A is a terpene with agonist properties at the kappa-opioid receptor, the binding site of endogenous dynorphins. Salvinorin-A is found in Salvia divinorum, a psychoactive plant traditionally used by the Mazatec people of Oaxaca, Mexico, for medicinal and spiritual purposes. Previous studies with the plant and salvinorin-A have reported psychedelic-like changes in perception, but also unusual changes in body awareness and detachment from external reality. Here we comprehensively studied the profiles of subjective effects of increasing doses of salvinorin-A in healthy volunteers, with a special emphasis on interoception. A placebo and three increasing doses of vaporized salvinorin-A (0.25, 0.50, and 1mg) were administered to eight healthy volunteers with previous experience in the use of psychedelics. Drug effects were assessed using a battery of questionnaires that included, among others, the Hallucinogen Rating Scale, the Altered States of Consciousness, and a new instrument that evaluates different aspects of body awareness: the Multidimensional Assessment for Interoceptive Awareness. Salvinorin-A led to a disconnection from external reality, induced elaborate visions and auditory phenomena, and modified interoception. The lower doses increased somatic sensations, but the highest dose led to a sense of a complete loss of contact with the body. Salvinorin-A induced intense psychotropic effects characterized by a dose-dependent gating of external audio-visual information and an inverted-U dose-response effect on body awareness. These results suggest a prominent role for the kappa opioid receptor in the regulation of sensory perception, interoception, and the sense of body ownership in humans.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Rupatadine Oral Solution Titration by Body Weight in Paediatric Patients Suffering from Allergic Rhinitis, A Population Pharmacokinetic Study

  • Santamaria, Eva
  • Izquierdo, Iñaki|||0000-0002-6963-6061
  • Valle, Marta|||0000-0002-3515-251X
Allergic rhinitis (AR) and chronic urticaria, both are treated in children with doses of second generation of antihistamines that have been mostly based on extrapolation of data obtained in adults. The objectives of this work were to develop a model to explain the pharmacokinetics (PK) of rupatadine, a second generation antihistamine, administered to children 2-11 years old and to calculate the non-compartmental PK parameters for two groups of age (2-5 and 6-11 years old) based on the individual Bayesian estimates from the selected model. Data from two PK studies with rupatadine oral solution (1 mg/mL) were pooled: Study A, an extensive blood sampling study performed in 11 children (6-11 years old) who received a single oral dose of rupatadine; and Study B, a sparse blood sampling study in 40 children (2-5 years old) receiving multiple oral doses. A simultaneous population PK model was developed using data available for all children. Using individual Bayesian estimates from the selected model, steady-state plasma concentrations for both studies were simulated and the non-parametric PK parameters were calculated for two age groups: 2-5 years (subgroup I) and 6-11 years (subgroup II). A two-compartment model with first-order absorption and elimination with clearance depending on body weight, better described the PK of rupatadine for 2-11 year old children. The plasma clearance dependence on weight was linear. The mean (SD) non-compartment PK parameters calculated using simulated plasma profiles at steady state were: C, 2.54 (1.26) vs 1.96 (0.52) ng/mL; AUC, 10.74 (3.09) vs 10.38 (4.31) ng/mL/h; and t, 12.28 (3.09) vs 15.94 (4.09) h, for children 6-11 and 2-5 years old, respectively. The PK of rupatadine depends on the weight of paediatric patients but not on their age. The dosage strategy adjusted by body weight in children 2-11 years old (2.5 mL if weight 10-25 kg, and 5 mL if ≥ 25 kg) provides similar exposure between the two groups of age, and to that obtained in adults with the 10 mg dose tablet formulation.